Clinical Trials Sponsored by EMDR Research Foundation

Total 4494 results

IrisZorg
Fonds Psychische Gezondheid; Dutch EMDR Association; EMDR Research Foundation

Completed

Eye Movement Desensitization and Reprocessing (EMDR) in Alcohol Dependent Patients

Alcohol Dependence

Netherlands
University of Zurich
EMDR Europe; Stiftung zur Förderung von Psychiatrie und Psychotherapie; EMDR... and other collaborators

Recruiting

EMDR Treatment in PTSD Following Cardiac Events (EMDR_PTSD_MI)

Myocardial Infarction | Posttraumatic Stress Disorder | Eye Movement Desensitization and Reprocessing

Switzerland
Parc de Salut Mar
Fundacion IMIM; EMDR Europe

Completed

Efficacy of EMDR Therapy, as Compared to Treatment as Usual, in Reducing Clinical Symptoms in People With HIV

PTSD | HIV/AIDS | Psychological Trauma

Spain
Parc de Salut Mar
Fundacion IMIM; EMDR Europe

Completed

EMDR in Psychiatric Inpatients With Severe Mental Disorder

Psychological Trauma | Severe Mental Disorder

Spain
EMD Serono Research & Development Institute, Inc.

Recruiting

The MS-LINK™ Outcomes Study

Multiple Sclerosis

United States
EMD Serono Research & Development Institute, Inc.

Completed

Oral Cladribine in Early Multiple Sclerosis (MS) (ORACLE MS)

Multiple Sclerosis

Lebanon, United States, Turkey, Sweden, Finland, France, Thailand, Serbia, Italy, United Kingdom, United Arab Emirates, Bulgaria, Belgium, Estonia, Argentina, Austria, Bosnia and Herzegovina, Canada, Croatia, Czechia, Georgia, Ger... and more
EMD Serono Research & Development Institute, Inc.

Recruiting

Next-Gen MS: Feed-forward PRO Data for MS Research

Multiple Sclerosis (MS)

United States
EMD Serono Research & Development Institute, Inc.

Completed

Avelumab in Participants With Merkel Cell Carcinoma (JAVELIN Merkel 200)

Carcinoma, Merkel Cell

United States, Spain, Australia, Italy, Germany, France, Japan
EMD Serono Research & Development Institute, Inc.

Completed

CLARITY Extension Study

Relapsing-Remitting Multiple Sclerosis

Croatia, United States, Bulgaria, France, Italy, Russian Federation, Turkey, United Kingdom, Estonia, Germany, Latvia, Lithuania, Poland, Austria, Brazil, Canada, Finland, Portugal, Greece, Serbia, Denmark, Ukraine, Saudi Arabia, Lebanon and more
EMD Serono Research & Development Institute, Inc.

Completed

A Phase 2 Study of Cladribine Add-on to Interferon-beta (IFN-beta) Therapy in Multiple Sclerosis (MS) Subjects With Active Disease (ONWARD) (ONWARD)

Multiple Sclerosis

United States, Italy, Russian Federation, Spain
SEARCH Research Foundation
US Military HIV Research Program

Recruiting

Post Analytic Treatment Interruption Study

HIV

Thailand
Thorax Research Foundation

Unknown

Pulmonary Rehabilitation Program and PROactive Tool (PROactive)

Chronic Obstructive Pulmonary Disease

Greece
Retina Research Foundation

Completed

Scotoma Reduction in AMD Patients Treated With Ranibizumab (SALVAGE)

Macular Degeneration

United States
Vision Research Foundation

Terminated

Pan-VEGF Blockade for the Treatment of Retinopathy of Prematurity (BLOCK-ROP)

Retinopathy of Prematurity

United States, Canada
Foregut Research Foundation

Recruiting

LINX Reflux Management System or Fundoplication Clinical Study in Patients With Hiatal Hernia >3 cm

Hiatal Hernia Large | Gastro Esophageal Reflux | Hiatal Hernia | Hiatal Hernia, Paraesophageal | Reflux, Gastroesophageal | Reflux Acid

United States
Electrophysiology Research Foundation

Recruiting

Treatment Of Atrial Fibrillation In Preserved Cardiac Function Heart Failure (TAP-CHF)

Heart Failure | Atrial Fibrillation | Diastolic Heart Failure

United States, Germany, Switzerland
Biomedical Research Foundation

Completed

Psychophysiologic Predictors of Post-deployment Mental Health Outcomes

Post-traumatic Stress Disorder

United States
German Research Foundation

Completed

Psychotherapy of Generalized Anxiety Disorder

Anxiety Disorders

Germany
German Research Foundation

Unknown

Force Enhancement of Musculus Quadriceps Femoris During and After Excentric Muscle Activity in Vivo

Healthy | Muscle Quadriceps Femoris

Germany
Retina Research Foundation

Unknown

Intravitreal Infliximab for Diabetic Macular Edema (DME) and Choroidal Neovascularization (CNV) (ITVR)

Macular Degeneration | Diabetic Retinopathy

United States
Foregut Research Foundation

Not yet recruiting

Ovitex in Paraesophageal and Large Hiatal Hernia Repair (OviPHeR)

Paraesophageal Hernia | Large Hiatal Hernia

United States
Sha Research Foundation

Active, not recruiting

Subtle Energy Transmission and Tao Calligraphy Mindfulness in Telomere Length in Peripheral Blood Leukocytes

Quality of Life | Telomere Length

Canada
Orthopaedic Research Foundation

Completed

Energy Dispersive Bracing for Conservative Treatment of Knee Osteoarthritis

Arthritis | Knee Osteoarthritis

United States
Cystinosis Research Foundation

Unknown

Cure Cystinosis International Registry (CCIR)

Cystinosis | Nephropathic Cystinosis | Renal Fanconi Syndrome

United States
Vision Research Foundation

Withdrawn

Pan-VEGF Blockade for the Treatment of Retinopathy of Prematurity (BLOCK-ROP) (BLOCK-ROP)

Retinopathy of Prematurity

United States, Canada
German Research Foundation

Completed

Effectiveness of the Teacher Module of the Prevention Program for Externalizing Problem Behaviour in Preschoolers (PEP-TE)

Behavior Problem of Childhood and Adolescence

Germany
German Research Foundation

Unknown

Guided Self-Help for Parents of Children With Externalizing Problem Behavior (FLOH)

Attention Deficit and Disruptive Behavior Disorders | Oppositional Defiant Disorder | Attention Deficit Hyperactivity Disorders

Germany
German Research Foundation

Unknown

Cognitive Determinants of Psychoeducation and Information in Psychoses (COGPIP)

Schizophrenia | Delusional Disorders (ICD-10)

Germany
German Research Foundation

Terminated

Interpersonal Psychotherapy for Severely Depressed Inpatients

Major Depression

Germany
EMD Serono Research & Development Institute, Inc.
Merck KGaA, Darmstadt, Germany

Recruiting

M1774 in Combination With Cemiplimab in Participants With Non-Squamous NSCLC (DDRiver NSCLC 322)

Non-Small Cell Lung Cancer

Korea, Republic of, United States, Japan
EMD Serono Research & Development Institute, Inc.
Merck KGaA, Darmstadt, Germany

Recruiting

Anti-CEACAM5 ADC M9140 in Advanced Solid Tumors

Colorectal Cancer

United States, Japan, Spain
EMD Serono Research & Development Institute, Inc.
Merck KGaA, Darmstadt, Germany

Recruiting

Study of M1774 in Combination With DNA Damage Response Inhibitor or Immune Checkpoint Inhibitor (DDRiver Solid Tumors 320)

Metastatic or Locally Advanced Unresectable Solid Tumors

United States, Canada, Spain
EMD Serono Research & Development Institute, Inc.
Merck KGaA, Darmstadt, Germany

Recruiting

Met Non Small Cell Cancer Registry (MOMENT)

Cancer

United States, Israel, Spain, Finland, France, Belgium, Netherlands, United Kingdom, Canada, Italy, Germany, Sweden, Austria, Czechia, Portugal
EMD Serono Research & Development Institute, Inc.
Merck KGaA, Darmstadt, Germany

Active, not recruiting

A Study of Suboptimally Controlled Participants Previously Taking Oral or Infusion DMDs for RMS (MASTER-2)

Multiple Sclerosis

United States
EMD Serono Research & Development Institute, Inc.
Merck KGaA, Darmstadt, Germany

Completed

M7824 Monotherapy in Locally Advanced or Metastatic Second Line (2L) Biliary Tract Cancer (Cholangiocarcinoma and Gallbladder Cancer)

Cholangiocarcinoma | Biliary Tract Cancer | Gallbladder Cancer

Korea, Republic of, United States, Taiwan, Italy, France, China, Japan, Spain, United Kingdom
EMD Serono Research & Development Institute, Inc.
Merck KGaA, Darmstadt, Germany

Completed

First-in-human Study of M4076 in Advanced Solid Tumors (DDRiver Solid Tumors 410)

Advanced Solid Tumors

Canada, United States
EMD Serono Research & Development Institute, Inc.
Merck KGaA, Darmstadt, Germany

Active, not recruiting

Tepotinib Phase II in NSCLC Harboring MET Alterations (VISION)

Advanced (Stage IIIB/IV) Non-small Cell Lung Cancer (NSCLC) With MET Exon 14 (METex14) Skipping Alterations or MET Amplification | Lung Adenocarcinoma Stage IIIB/IV

Spain, Taiwan, United States, Korea, Republic of, Netherlands, Israel, Belgium, Italy, China, France, Germany, Japan, Poland, Austria, Switzerland
EMD Serono Research & Development Institute, Inc.
Merck KGaA, Darmstadt, Germany

Terminated

First in Human Dose Escalation of M3258 as a Single Agent and Expansion Study of M3258 in Combination With Dexamethasone

Multiple Myeloma

United States, France
EMD Serono Research & Development Institute, Inc.
Merck KGaA, Darmstadt, Germany

Completed

First in Human Study of M4344 in Participants With Advanced Solid Tumors

Solid Tumor | Advanced Solid Tumor

Spain, United States, Netherlands, United Kingdom
EMD Serono Research & Development Institute, Inc.
Merck KGaA, Darmstadt, Germany

Completed

Avelumab in First-Line Maintenance Gastric Cancer (JAVELIN Gastric 100)

Unresectable, Locally Advanced or Metastatic, Adenocarcinoma of the Stomach, or of the Gastro Esophageal Junction

United States, Spain, Italy, Australia, Russian Federation, Taiwan, Korea, Republic of, Thailand, Canada, Turkey, Germany, Romania, United Kingdom, Hungary, Brazil, France, Japan
EMD Serono Research & Development Institute, Inc.
Merck KGaA, Darmstadt, Germany

Completed

Study of M5049 in Participants With COVID-19 Pneumonia (ANEMONE)

Coronavirus Disease 2019

United States, Brazil, Philippines
EMD Serono Research & Development Institute, Inc.
Merck KGaA, Darmstadt, Germany

Terminated

Study of Evobrutinib in Participants With RMS

Relapsing-remitting Multiple Sclerosis

United States, Germany
EMD Serono Research & Development Institute, Inc.
Merck KGaA, Darmstadt, Germany

Completed

Avelumab in Third-Line Gastric Cancer (JAVELIN Gastric 300)

Unresectable, Recurrent, Locally Advanced or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma | Gastric Cancer Third Line

Spain, Italy, Australia, Korea, Republic of, Belgium, France, Poland, United States, Czechia, Germany
EMD Serono Research & Development Institute, Inc.
Merck KGaA, Darmstadt, Germany

Terminated

First-in-Human Study of MS201408-0005A as Single Agent and in Combinations

Metastatic or Locally Advanced Unresectable Solid Tumors

United States
Veterans Medical Research Foundation
ResMed Foundation

Unknown

Adaptive Servo-Ventilation In Acute Heart Failure Patients Protecting the Heart and Kidneys (ASLEEP PK)

Heart Failure | Sleep Apnea, Obstructive

United States
Barcelonabeta Brain Research Center, Pasqual Maragall...
Fundacion SARquavitae

Completed

Experimental Study to Validate the "Therapeutic Game" CONEM-BETA

Dementia | Alzheimer's Disease

Spain
EMD Serono Research & Development Institute, Inc.
Merck KGaA, Darmstadt, Germany

Recruiting

Phase 1b Safety Study of Xevinapant, Weekly Cisplatin, and RT in Participants With Unresected LA SCCHN (HyperlynX)

Head and Neck Cancer

Taiwan, United States, Korea, Republic of, Spain, Belgium
EMD Serono Research & Development Institute, Inc.
Merck KGaA, Darmstadt, Germany

Recruiting

Phase III Xevinapant (Debio 1143) and Radiotherapy in Resected LA SCCHN, High Risk, Cisplatin-ineligible Participants (XRAY VISION)

Head and Neck Cancer

United States, China, Belgium, Taiwan, Korea, Republic of, Japan, Israel, Brazil, Greece, Mexico, United Kingdom, Argentina, Austria, Czechia, France, Georgia, Germany, India, Italy, Romania, Spain, Switzerland, Netherlands, Poland, Por...
EMD Serono Research & Development Institute, Inc.
Merck KGaA, Darmstadt, Germany

Recruiting

Study of Avelumab in Combination With Lenvatinib for Children With Primary CNS Tumors

Central Nervous System Tumors

Korea, Republic of, United States, Canada, Germany, France
EMD Serono Research & Development Institute, Inc.
Merck KGaA, Darmstadt, Germany

Active, not recruiting

Tuvusertib (M1774) in Participants With Metastatic or Locally Advanced Unresectable Solid Tumors (DDRiver Solid Tumors 301)

Metastatic or Locally Advanced Unresectable Solid Tumors

United States, China, Spain, Japan, United Kingdom

Clinical Trials Sponsored by EMDR Research Foundation

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Canada

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations